Swine fever vaccines are used for prevention of African swine fever and classical swine fever in pigs. African swine fever is one of the most devastating diseases affecting domestic swine populations. The disease is easily transmissible and can quickly spread, causing significant economic losses. Several outbreaks of African swine fever have been reported across various regions in recent years, which is driving the demand for effective vaccines. Swine fever vaccines effectively provide immunity against the viruses and help control disease transmission.
The global Swine Fever Vaccine Market is estimated to be valued at Us$ 3,323.81 Bn in 2023 and is expected to exhibit a CAGR Of 11% over the forecast period 2024 To 2031, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The increasing incidence of African swine fever outbreaks across various countries is a major factor driving the growth of the swine fever vaccine market. As per data from Food and Agriculture Organization, between 2018 to 2021, there were over 50 outbreaks of African swine fever reported globally, majorly impacting China, European Union countries, and Russia. Furthermore, supportive government initiatives and funding for vaccine development against swine fever viruses is also promoting research activities. For instance, in 2021, Chinese government allocated CNY 2.5 billion (US$ 395 million) for African swine fever vaccine research and development. Rising awareness regarding economic losses due to swine fever outbreaks is further fueling the adoption of vaccination practices among pig farmers.
SWOT Analysis
Strength: The swine fever vaccine market has high growth potential due to increasing prevalence of African swine fever. Vaccination is the key method for disease control and prevention. Large scale production capacity and established distribution channel ensures adequate supply of vaccines.
Weakness: Development of effective vaccines against swine fever is a challenge due to complexity of the virus. High production costs and lengthy approval timelines limit commercial availability of newer vaccines. Lack of standardized testing protocols impacts vaccine efficacy results.
Opportunity: Rising consumption of pork products along with growing meat export business in Asia Pacific and Europe drives vaccine adoption. Collaboration between industry and academia can expedite vaccine R&D. Government support through funding and favorable regulations boost market prospects.
Threats: Frequent virus mutation reduces vaccine effectiveness over time. Threat from alternative treatment options and public skepticism over vaccine safety remain challenges. Trade barriers and geopolitical issues disrupt supply chain.
Key Takeaways
The Global Swine Fever Vaccine Market Demand is expected to witness high growth.
Regional analysis related content comprises rapid spread of African swine fever across Asia Pacific, Europe and Americas will drive the need for effective vaccination programs in these regions. China reported over one million pig deaths and accounts for over 50% of global pork production, establishing China as the dominating as well as fastest growing regional market for swine fever vaccines.
Key players operating in the swine fever vaccine market are dbWatch AS, eG Innovations, Heroix Corporation, Nagios Enterprises, LLC, Paessler AG, Quest Software Inc., Red Gate Software Ltd., Sematext Group, SolarWinds Worldwide, LLC, and VirtualMetric. These players have adopted various strategies to increase their market penetration and strengthen their position in the industry. The swine fever vaccine market size for 2024 is US$ 3323.81 Bn registering a CAGR of 11% during the forecast period of 2024 to 2031.
Get more insights on this topic :
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek